Company News
From Lab To Life Podcast: Episode 2
The role of a Human Research Ethics Committee (HREC) is to ensure that all kinds of research involving or impacting on humans conform to the highest standards of ethical practice and academic integrity. In this episode, Behind Closed Doors, we meet four members of Bellberry’s HRECs to understand what motivates people to take on this […]
Read More
Bellberry Not-For-Profit Business of the Year Award Winners!
Bellberry were thrilled to win the 2023 Not-For-Profit Business of the Year Award at Friday’s South Australian Premier’s Business and Export Awards! What a great way to kick off our 20th year celebrations – thanks to our amazing Bellberry community.
Read More
Clinical Trial Activity Report (CTAR) 2022
On International Clinical Trials Day, we’re proud to publish the Bellberry Clinical Trial Activity Report for 2022. This annual publication represents over one third of the Australia wide CTN trial activity across the development lifecycle. This report demonstrates capability and capacity in a broad range of research areas. It also captures the originating funding location […]
Read More
Bellberry Clinical Trial Activity Report 2020
Bellberry is the largest independent reviewer of CTN trials in Australia. This year on Clinical Trials Day, we’re pleased to share a summary report which describes research activity overseen by Bellberry HRECs through 2020. This activity report represents a significant proportion of the Australia wide CTN trial activity across the development lifecycle. It demonstrates […]
Read More
Bellberry receives Australian first recognition
Bellberry awarded AAHRPP accreditation Bellberry has become the first organisation in Australia to achieve international accreditation for excellence and ethically sound processes in running Human Research Ethics Committees (HRECs). The recognition has come from the Association for the Accreditation of Human Research Protection Programs (AAHRPP), which is based in the USA. The AAHRPP site accreditation team […]
Read More
Launch of Exciting New Australian Clinical Trials Initiative, CT:IQ!
We are delighted to announce that Bellberry, ACTA, NHMRC CTC and The George Institute have formed a consortium ‘Clinical Trials: Impact & Quality (CT:IQ)’. The consortium’s mission is “to develop and implement recommendations that will improve the impact, quality and efficiency of clinical trials, leading to more rapid, lower cost and higher quality evaluation of […]
Read More
Crossover Conference Papers Published
In October 2014 Bellberry hosted the Crossover conference, an international expert scientific meeting that addressed the challenges of early treatment switching in clinical trial design for oncology. A further scientific meeting in 2015 allowed for the development and launch of best practice guidelines for trial design and statistical methods from an international expert panel. Bellberry […]
Read More